Salvage radiotherapy after prostatectomy - what is the best time to treat?
暂无分享,去创建一个
T. Wiegel | D. Bottke | A. Siegmann | W. Hinkelbein | K. Miller | J. Faehndrich | G. Lohm | D. Bartkowiak | M. Brachert
[1] L. Kiemeney,et al. Efficacy and tolerance of salvage radiotherapy after radical prostatectomy, with emphasis on high-risk patients suited for adjuvant radiotherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[2] C. Perneel,et al. A multi-institutional analysis comparing adjuvant and salvage radiation therapy for high-risk prostate cancer patients with undetectable PSA after prostatectomy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] T. Wiegel,et al. The German S3 Guideline Prostate Cancer , 2010, Strahlentherapie und Onkologie.
[4] T. Henkel,et al. Strahlentherapie des Prostatakarzinoms in der neuen S3-Leitlinie , 2010, Der Urologe.
[5] T. Wiegel,et al. Second Malignancies in High‑Dose Areas of Previous Tumor Radiotherapy , 2010, Strahlentherapie und Onkologie.
[6] T. Henkel,et al. Strahlentherapie des Prostatakarzinoms in der neuen S3-Leitlinie , 2010, Der Urologe.
[7] M. Heckman,et al. Late toxicity after postprostatectomy salvage radiation therapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[8] T. Wiegel,et al. Postoperative Radiotherapy for Advanced Prostate Cancer , 2009, Strahlentherapie und Onkologie.
[9] N. Willich,et al. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] T. Wiegel,et al. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study. , 2009, International journal of radiation oncology, biology, physics.
[11] E. Messing,et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. , 2009, The Journal of urology.
[12] Kara Hamilton,et al. Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy. , 2008, International journal of radiation oncology, biology, physics.
[13] M. Kattan,et al. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. , 2005, The Journal of urology.
[14] T. Wiegel,et al. Adjuvant radiotherapy after radical prostatectomy , 2007 .
[15] Richard K Valicenti,et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] T. Wiegel,et al. Adjuvant Radiotherapy after Radical Prostatectomy: Indications, Results and Side Effects , 2007, Urologia Internationalis.
[17] E. Sacco,et al. Clinical and Pathological Characteristics of Patients Presenting with Biochemical Progression after Radical Retropubic Prostatectomy for Pathologically Organ-Confined Prostate Cancer , 2006, Urologia Internationalis.
[18] A. Haese*,et al. Anatomic radical retropubic prostatectomy—long-term recurrence-free survival rates for localized prostate cancer , 2006, World Journal of Urology.
[19] W. Catalona,et al. Salvage radiation therapy for prostate specific antigen progression following radical prostatectomy: 10-year outcome estimates. , 2005, The Journal of urology.
[20] M. Piérart,et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) , 2005, The Lancet.
[21] E. Bergstralh,et al. Prostate specific antigen doubling time subsequent to radical prostatectomy as a prognosticator of outcome following salvage radiotherapy. , 2004, The Journal of urology.
[22] William J Catalona,et al. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. , 2004, The Journal of urology.
[23] E. B. Butler,et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. , 2004, JAMA.
[24] S. Schild,et al. Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy. , 2003, The Journal of urology.
[25] A. Zietman,et al. Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] A. Zietman,et al. Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: analysis of efficacy and prognostic factors. , 2002, Urology.
[27] D W Hillman,et al. Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. , 2000, The Journal of urology.
[28] M S Anscher,et al. Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years. , 2000, International journal of radiation oncology, biology, physics.
[29] D. Grignon,et al. Vesicourethral anastomosis biopsy after radical prostatectomy: predictive value of prostate-specific antigen and pathologic stage. , 1999, Urology.
[30] A. Zietman,et al. Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. , 1997, International journal of radiation oncology, biology, physics.
[31] S. Schild,et al. The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. , 1996, The Journal of urology.
[32] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .